October 23, 2019 (updated 10-24) — It is unclear to me what has happened with a summary judgement of this Merck whistleblower case. The last piece of information I received said a summary judgment has been entered, and sealed at the request of the whistleblowers.
I was also told on the evening of 10-23-19 via email it appeared that the sealed documents relate to extending the deadline for filing a motion for summary judgment (a procedural move).
In 2010 a lawsuit was filed where a Merck whistleblower alleged the company used fraudulent data relating to the mumps component of their MMR vaccine to get a monopoly on the market. Today we are seeing mumps outbreaks near epidemic levels in fully vaccinated communities that appear to be directly related to this original fraud.
This evening I received a tweet claiming there has been a SEALED VERDICT in this court case, and that Merck’s stock has been dropping all week – down 4% today alone.
However I just received an email from a very reliable source that the sealed documents relate to extending the deadline for filing a motion for summary judgment (a procedural move). Then shortly after receiving that email I received the following information:
A summary judgment has been entered, and sealed at the request of the whistleblowers.
Here is the tweet I recieved:
Additional Background Info:
Keller Grover LLP represents Stephen Krahling and Joan Wlochowski in a False Claims Act case originally filed in 2010 and now pending in the United States District Court for the Eastern District of Pennsylvania, United States ex rel. Krahling and Wlochowski v. Merck & Co., Case No. 10-cv-4374. Krahling and Wlochowski allege in their complaint that their former employer, Merck & Co., defrauded the government for more than a decade in an ongoing scheme to sell the government a mumps vaccine that is mislabeled, misbranded, adulterated and falsely certified as having an efficacy rate that is significantly higher than it actually is. The federal government purchases more than half of all vaccines sold in the United States, including the mumps vaccine. While the United States declined to intervene, it filed a Statement of Interest in response to Merck’s motion to dismiss making clear the government has “a strong interest in the outcome, even though it has not intervened in the case.” The government appeared at the hearing on Merck’s motion along with counsel for Krahling and Wlochowski and emphasized its position for the Court. Merck’s motion to dismiss was subsequently denied.
Update – December 6, 2019 — Today Robert F. Kennedy Jr. wrote a report titled “Merck Whistleblower Case Proceeds Towards Resolution” which opens as follows:
As the Merck MMR whistle blower case proceeds toward a resolution that increasingly appears to spell doom for Merck’s scandal ridden MMRII blockbuster, U.S. Department of Health and Human Services (DHHS) officials are scrambling to get Glaxo’s version of the MMR teed up to fill the coming vacuum. https://childrenshealthdefense.org/news/merck-whistleblower-case-proceeds-toward-a-resolution/
It is very encouraging to see RFK Jr. believes Merck is about to lose this case.